GlassScriptPhysician profile
Jae Y Lee
NPI 1114918588
$5,302.56
in general payments reported to CMS, 2019-2025
41 companies · $920 in 2025
The $920 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,200 · 2020: $379 · 2021: $645 · 2022: $597 · 2023: $833 · 2024: $729 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,481.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,048.69 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $829.99 | 2019-2025 | Farxiga, Airsupra |
| Amgen INC. | $770.80 | 2019-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $580.31 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.01 | 2019-2023 | Tradjenta, Synjardy, Jardiance |
| Allergan, INC. | $167.62 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $150.48 | 2019-2021 | |
| Novo Nordisk INC | $142.90 | 2019-2025 | Rybelsus, Ozempic |
| Abbott Laboratories | $142.10 | 2022 | |
| Sumitomo Pharma America, INC. | $107.88 | 2023-2025 | Gemtesa |
| Hikma Pharmaceuticals USA | $85.08 | 2019-2021 | |
| Exact Sciences Corporation | $67.78 | 2023-2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $66.03 | 2023-2024 | |
| Lilly USA, LLC | $63.75 | 2020-2025 | Mounjaro, Kisunla, Zepbound |
| Merck Sharp & Dohme LLC | $60.98 | 2019-2023 | Belsomra, Steglatro |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jae Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.